Related Experiment Video

Updated: May 16, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

703

Reply to "Metabolic (dysfunction)-associated fatty liver disease metrics and contributions: Correspondence"

Maito Suoh1, Saeed Esmaili1, Mohammed Eslam1

  • 1Storr Liver Centre, The Westmead Institute for Medical Research, Westmead Hospital and The University of Sydney, 176 Hawkesbury Rd, Westmead, NSW, 2145, Australia.

Hepatology International
|April 2, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
08:35

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

Published on: May 18, 2021

6.1K
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

15.8K

Related Experiment Videos

Last Updated: May 16, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

703
A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
08:35

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

Published on: May 18, 2021

6.1K
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

15.8K

Related Concept Videos

Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

873
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
873
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

30.0K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
30.0K

Articles linked to this work by shared authors, journal, and citation graph.

Nationwide Socioeconomic Evaluation of Direct-Acting Antivirals for Chronic Hepatitis C Virus Infection in Japan Between 2014 and 2023.

Journal of viral hepatitis·2026

Prediction model for successful radiocephalic arteriovenous fistula creation in patients with diabetic nephropathy.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2019

Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology.

Nature reviews. Gastroenterology & hepatology·2019

IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis.

Scientific reports·2019

Spectroscopic and quantum computational study on naproxen sodium.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2019

Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation.

Hepatology (Baltimore, Md.)·2019

Comparative risk of hepatocellular carcinoma and mortality among initiators of GLP-1 receptor agonists versus other glucose-lowering therapies: a target trial emulation.

Hepatology international·2026

Hepatic fibrosis severity assessed by FIB-4 index is independently associated with reduced kidney function in patients with metabolic dysfunction-associated steatotic liver disease: a nationwide multicenter study from Türkiye.

Hepatology international·2026

HBV RNA, HBcrAg, and HBsAg levels at year 6 do not predict HCC risk in patients with cirrhosis on long-term entecavir therapy.

Hepatology international·2026

Bepirovirsen induces innate immune proteins independent of HBV.

Hepatology international·2026

National guideline for hepatitis B elimination in Thailand: a decentralized health system model for expanding diagnosis and treatment.

Hepatology international·2026

A global consensus on the critical care management of acute-on-chronic liver failure patients: the APASL ACLF Beijing Position Paper.

Hepatology international·2026

Lactiplantibacillus plantarum Q180 Mitigates Early High-Fat Diet-Induced Metabolic Dysfunction-Associated Steatotic Liver Disease by Modulating Gut-Liver Axis Inflammation and Barrier Integrity.

Journal of medicinal food·2026

Altered amino acids and acylcarnitines profile in infantile intrahepatic cholestasis liver disease: implication for Traditional Chinese Medicine syndrome differentiation.

Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan·2026

Persistent inflammation, immunosuppression, and catabolism are associated with impaired lymphocytic mitochondrial metabolism during the early phase of sepsis. A single-center, prospective cohort study.

Anaesthesiology intensive therapy·2026

Systemic Signatures Differentiating Varicocele-Associated Semen Quality Heterogeneity: An Exploratory Multi-Omics Pilot Study.

Andrology·2026

Time-resolved volatile profiles and molecular-species lipid remodeling during lipase treatment of anhydrous milk fat.

Food research international (Ottawa, Ont.)·2026

Scleroglucan from Agroathelia rolfsii ameliorates glucolipid metabolic dysfunction in high-fat diet-fed mice and is associated with gut microbiota and metabolite changes.

Food research international (Ottawa, Ont.)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us